RDE | Jotup

RDE, Inc. Reports $86.6 Million Revenue for 2023

Retrieved on:

Wednesday, April 10, 2024

Ketan, TJ Maxx, Target, Starbucks, Acceleration, OTCQB, CardCash, Security (finance), RDE, Acquisition, The Home Depot, Intellectual property, IOS, Cryptocurrency

Schaumburg, IL, April 10, 2024 (GLOBE NEWSWIRE) -- RDE, Inc. (OTCQB: RSTN) (“RDE” or “Company”), the owner and operator of leading digital platforms, Restaurant.com and CardCash.com, with a focus on incentives and rewards in retail, dining & entertainment experiences, today reported its financial results for the year ended December 31, 2023 and provided a business update.

Key Points:

Of note, due to accounting rules, recognized revenue represents only revenue derived from CardCash.com.
Going forward in 2024, both revenue from CardCash.com and Restaurant.com will be recognized.
“We are extremely pleased with our financial performance in 2023 and believe the steps we have taken, and the efficiencies gained, will translate into increased profitability in 2024.
Full 2023 year-end financial information is available in the Company’s Form 10-K filed with the Securities and Exchange Commission.

Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)

Retrieved on:

Wednesday, April 10, 2024

Hypertelorism, DLT, Safety, Radiation, Pancreatic cancer, TSX, PR, Cancer, LFT, Regulatory T cell, Patient, MDNA, RDE, Duodenal cancer, Toxicity, Melanoma, BCC, MCC, AACR, VLS, MSI-H, PD, NK, Combination therapy, Pharmaceutical industry

March 22, 2024) include:

Key Points:

March 22, 2024) include:
Acceptable safety profile: No dose limiting toxicity (DLT) reported and no evidence of vascular leak syndrome (VLS).
A new lymph node lesion developed during a 8-week MDNA11 treatment break (vacation) was treated with a single course of radiotherapy prior to resumption of MDNA11.
A new lymph node lesion developed at week 16 while baseline target and non-target lesions remained stable or decreased.
Monotherapy expansion is continuing to enroll patients with metastatic melanoma, non-melanoma skin cancers (cSCC, MCC, and BCC) and MSI-H/dMMR tumors.

Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)

Retrieved on:

Tuesday, April 9, 2024

Toxicity, PR, Combination therapy, VLS, MSI-H, PD, LFT, RDE, Duodenal cancer, Patient, Hypertelorism, Radiation, MCC, MDNA, AACR, TSX, DLT, Pancreatic cancer, Safety, Regulatory T cell, Melanoma, Cancer, BCC, NK, Pharmaceutical industry

March 22, 2024) include:

Key Points:

March 22, 2024) include:
Acceptable safety profile: No dose limiting toxicity (DLT) reported and no evidence of vascular leak syndrome (VLS).
A new lymph node lesion developed during a 8-week MDNA11 treatment break (vacation) was treated with a single course of radiotherapy prior to resumption of MDNA11.
A new lymph node lesion developed at week 16 while baseline target and non-target lesions remained stable or decreased.
Monotherapy expansion is continuing to enroll patients with metastatic melanoma, non-melanoma skin cancers (cSCC, MCC, and BCC) and MSI-H/dMMR tumors.

United States Gift Card Market Forecasted to Reach $267.3 Billion by 2028 with A 5.7% CAGR, Reveals Q1 2024 Report - ResearchAndMarkets.com

Retrieved on:

Friday, March 29, 2024

The "United States Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "United States Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering.
The gift card market in the U.S. is forecast to increase from US$199.9 billion in 2023 to reach US$267.3 billion by 2028.
In the United States, the trend of mergers and acquisitions is also growing rapidly in the gift card sector.
Consequently, to provide gift card holders with an effective solution, United Airlines launched a gift card exchange program in the United States.

United States Gift Card and Incentive Card Market Growth Dynamics Databook 2024, Featuring Walmart, Home Depot, Amazon, Target, Lowe`s, CVS Pharmacy, Walgreens, Kroger and Publix

Retrieved on:

Wednesday, March 27, 2024

Mastercard, Southwest Airlines, ROI, Blackhawk Network Holdings, Target, Visa, Growth, Partnership, RDE, Acquisition, API, Bankrate, Starbucks, Online shopping

DUBLIN, March 27, 2024 /PRNewswire/ -- The "United States Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering.

Key Points:

DUBLIN, March 27, 2024 /PRNewswire/ -- The "United States Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook) - Q1 2024 Update" report has been added to ResearchAndMarkets.com's offering.
In the United States, the trend of mergers and acquisitions is also growing rapidly in the gift card sector.
Consequently, to provide gift card holders with an effective solution, United Airlines launched a gift card exchange program in the United States.
In-depth understanding of gift card and incentive card market dynamics: Understand market opportunity, key trends and drivers along with five-year forecast (2019-2028) for gift cards and incentive cards in the United States.

Spectaire Enhances Production to 500 Units Monthly Due to Unprecedented Market Demand

Retrieved on:

Thursday, February 29, 2024

RDE, MLab, European emission standards, Gas, Real, Fossil fuel, Renewable energy

To meet this extraordinary demand and guarantee prompt delivery to its clientele, Spectaire is substantially upgrading its production facilities.

Key Points:

To meet this extraordinary demand and guarantee prompt delivery to its clientele, Spectaire is substantially upgrading its production facilities.
"Elevating our production to 500 units monthly by August 2024 is a significant achievement for Spectaire.
Moreover, Spectaire acknowledges the collaboration with partners and customers in developing the latest Oil & Gas units.
With flexible subscription plans ranging from $100 monthly to $10000 annually per unit, Spectaire is set to make a significant impact on global emissions reduction efforts.

Ankyra Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Dose Escalation Cohort Evaluating ANK-101, an Anchored Immune Medicine, for Solid Tumors

Retrieved on:

Tuesday, March 5, 2024

Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced the first patient dosed in the dose escalation cohort in a Phase 1 clinical study evaluating ANK-101, a tumor-directed, anchored immune medicine for solid tumors.

Key Points:

Ankyra Therapeutics, a clinical stage biotechnology company pioneering anchored immunotherapies to treat cancer, today announced the first patient dosed in the dose escalation cohort in a Phase 1 clinical study evaluating ANK-101, a tumor-directed, anchored immune medicine for solid tumors.
ANK-101 is currently under investigation in patients with advanced solid tumors who have failed standard of care treatments.
In multiple preclinical models, ANK-101 demonstrated increased immune cell infiltration into tumors without systemic toxicity.
“These data will provide a roadmap for advancing ANK-101 through clinical development and for identifying appropriate clinical indications for future trials,” said Joe Elassal, M.D., MBA, Chief Medical Officer of Ankyra Therapeutics.

BullseyeEngagement Welcomes Marketing Expert Betty Gower to Advisory Board

Retrieved on:

Wednesday, February 7, 2024

BullseyeEngagement LLC , leading provider of cloud-based human capital management software solutions, today proudly announces the appointment of Betty Gower to its esteemed Advisory Board.

Key Points:

BullseyeEngagement LLC , leading provider of cloud-based human capital management software solutions, today proudly announces the appointment of Betty Gower to its esteemed Advisory Board.
With a distinguished career marked by successful leadership and expertise in marketing for both B2C and B2B companies, Ms. Gower brings a wealth of experience and strategic vision to BullseyeEngagement.
To BullseyeEngagement, Ms. Gower brings expertise in crafting impactful brand messaging, developing effective content marketing, and building efficient growth pipelines.
Expressing her enthusiasm, Ms. Gower stated, "I am delighted to have joined BullseyeEngagement’s advisory board.

RDE, Inc. Submits Application for Uplisting to the Nasdaq Capital Market

Retrieved on:

Tuesday, January 23, 2024

Ketan, RSTN, OTCQB, Acquisition, RDE

Schaumburg, IL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- RDE, Inc. (OTCQB: RSTN) (“RDE” or “Company”), the owner and operator of leading digital platforms, Restaurant.com and CardCash.com, with a focus on incentives and rewards in retail, dining & entertainment experiences, is pleased to announce it has submitted an application to uplist the Company’s common shares on the Nasdaq Capital Market® (“Nasdaq”).

Key Points:

Schaumburg, IL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- RDE, Inc. (OTCQB: RSTN) (“RDE” or “Company”), the owner and operator of leading digital platforms, Restaurant.com and CardCash.com, with a focus on incentives and rewards in retail, dining & entertainment experiences, is pleased to announce it has submitted an application to uplist the Company’s common shares on the Nasdaq Capital Market® (“Nasdaq”).
We believe this uplisting will increase our corporate visibility and enhance shareholder value for investors who truly appreciate the huge potential of the consumer gift card industry.”
The listing of the Company’s common shares on Nasdaq is subject to the approval of Nasdaq and the satisfaction of all applicable listing criteria and requirements.
No assurance can be given that such application will be approved or that such listing will be completed.
RDE stock will continue to trade on the OTCQB under its current symbol RSTN pending approval of a Nasdaq listing.

Spectaire Launches into European Trucking Market with Signed Distribution Agreement

Retrieved on:

Thursday, January 11, 2024

European, Partnership, RDE, European emission standards, MLab, Renewable energy

WATERTOWN, Mass., Jan. 11, 2024 /PRNewswire/ -- Spectaire Holdings Inc. (NASDAQ: SPEC), an innovator in air quality monitoring and emissions reduction technology, today announced a strategic distribution agreement with MLab, alongside their service and distribution partner Mosolf, to bring the cutting-edge AireCore emissions measurement system to the European trucking market.

Key Points:

WATERTOWN, Mass., Jan. 11, 2024 /PRNewswire/ -- Spectaire Holdings Inc. (NASDAQ: SPEC), an innovator in air quality monitoring and emissions reduction technology, today announced a strategic distribution agreement with MLab, alongside their service and distribution partner Mosolf, to bring the cutting-edge AireCore emissions measurement system to the European trucking market.
This partnership marks a significant step in Spectaire's expansion, leveraging MLabs' network and Mosolf's expertise in trucking, sales, service, and distribution to introduce AireCore systems across Europe.
The European commercial trucking market represents a vast opportunity for Spectaire's technology.
Additional Information: For more details on the Spectaire and MLab partnership and the AireCore emissions measurement technology, please visit www.spectaire.com .